The achondroplasia market refers to the global industry focused on the development, production, and commercialization of therapies, diagnostics, and supportive care for achondroplasia, a rare genetic disorder affecting bone growth and causing disproportionate dwarfism. The process includes all research and development activities, regulatory approval procedures and construction of healthcare facilities, which together work to enhance diagnosis capabilities and treatment effectiveness and the quality of life of patients